Dilantin and Aredia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilantin (phenytoin sodium) and Aredia (pamidronate disodium). Common drug interactions include hypoaesthesia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Dilantin and Aredia. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Dilantin?

Dilantin has active ingredients of phenytoin sodium. It is often used in epilepsy. eHealthMe is studying from 20,859 Dilantin users. Check the latest studies of Dilantin.

What is Aredia?

Aredia has active ingredients of pamidronate disodium. It is often used in breast cancer. eHealthMe is studying from 15,365 Aredia users. Check the latest studies of Aredia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

57 people who take Dilantin and Aredia together, and have interactions are studied.

Dilantin and Aredia drug interactions.

What are the common drug interactions of Dilantin and Aredia, by gender? *:

female:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Back pain
  6. Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone)
  7. Spinal osteoarthritis (joint cartilage loss in spine)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Nausea (feeling of having an urge to vomit)
  10. Scoliosis (a medical condition in which a person's spine is curved from side to side)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  3. Asthenia (weakness)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Cholecystitis (infection of gallbladder)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  8. Device related infection
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))

What are the common drug interactions of Dilantin and Aredia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anticonvulsant drug level below therapeutic
  2. Asthenia (weakness)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Fatigue (feeling of tiredness)
  5. Metastases to central nervous system (cancer spreads to central nervous system)
  6. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  7. Dyspnoea (difficult or laboured respiration)
  8. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

40-49:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Back pain
  3. Cholecystitis (infection of gallbladder)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Neuropathy peripheral (surface nerve damage)

50-59:

  1. Spinal osteoarthritis (joint cartilage loss in spine)
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Bone disorder
  4. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Intervertebral disc protrusion (spinal disc protrusion)
  7. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  8. Onychomycosis (fungal infection of the nail)
  9. Osteosclerosis (an elevation in bone density)
  10. Rib fracture

60+:

  1. Blood lactate dehydrogenase increased
  2. Anaemia (lack of blood)
  3. Blood creatinine increased
  4. Bone disorder
  5. Bone fissure
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Bruxism (habitual grinding of the teeth, typically during sleep)
  8. Cellulitis (infection under the skin)
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Confusional state

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 14 people, 24.56%
  2. Osteoporosis (bones weak and more likely to break): 11 people, 19.30%
  3. Breast Cancer Metastatic: 11 people, 19.30%
  4. Ovarian Cancer (cancer of ovary): 7 people, 12.28%
  5. Neoplasm Malignant (cancer tumour): 7 people, 12.28%
  6. Migraine (headache): 7 people, 12.28%
  7. Hot Flush (sudden feelings of heat): 7 people, 12.28%
  8. Discomfort: 7 people, 12.28%
  9. Granulocyte Count Decreased: 6 people, 10.53%
  10. Metastases To Bone (cancer spreads to bone): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Dilantin and Aredia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dilantin and Aredia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dilantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aredia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aredia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on phenytoin sodium and pamidronate disodium (the active ingredients of Dilantin and Aredia, respectively), and Dilantin and Aredia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: